Cargando…

Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis

Hypersensitivity reactions to dapsone are common and potentially fatal adverse drug reactions. Herein, we report a case of a 45-year-old female who presented with fever, generalized desquamating rashes, and icterus three weeks after initiation of dapsone therapy for leprosy neuritis. She was diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Pahadiya, Hans Raj, Lakhotia, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057120/
https://www.ncbi.nlm.nih.gov/pubmed/33889465
http://dx.doi.org/10.7759/cureus.14026
_version_ 1783680775330201600
author Pahadiya, Hans Raj
Lakhotia, Manoj
author_facet Pahadiya, Hans Raj
Lakhotia, Manoj
author_sort Pahadiya, Hans Raj
collection PubMed
description Hypersensitivity reactions to dapsone are common and potentially fatal adverse drug reactions. Herein, we report a case of a 45-year-old female who presented with fever, generalized desquamating rashes, and icterus three weeks after initiation of dapsone therapy for leprosy neuritis. She was diagnosed to have dapsone hypersensitivity syndrome (DHS) with leukemoid reaction and thrombocytosis. Dapsone was immediately discontinued, and she has treated with prednisolone 50 mg daily for a month and tapered over the next month. She has improved completely. DHS, leukemoid reaction, and severe thrombocytosis, or these adverse drug reactions to dapsone have rarely been reported.
format Online
Article
Text
id pubmed-8057120
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-80571202021-04-21 Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis Pahadiya, Hans Raj Lakhotia, Manoj Cureus Family/General Practice Hypersensitivity reactions to dapsone are common and potentially fatal adverse drug reactions. Herein, we report a case of a 45-year-old female who presented with fever, generalized desquamating rashes, and icterus three weeks after initiation of dapsone therapy for leprosy neuritis. She was diagnosed to have dapsone hypersensitivity syndrome (DHS) with leukemoid reaction and thrombocytosis. Dapsone was immediately discontinued, and she has treated with prednisolone 50 mg daily for a month and tapered over the next month. She has improved completely. DHS, leukemoid reaction, and severe thrombocytosis, or these adverse drug reactions to dapsone have rarely been reported. Cureus 2021-03-21 /pmc/articles/PMC8057120/ /pubmed/33889465 http://dx.doi.org/10.7759/cureus.14026 Text en Copyright © 2021, Pahadiya et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Pahadiya, Hans Raj
Lakhotia, Manoj
Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis
title Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis
title_full Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis
title_fullStr Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis
title_full_unstemmed Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis
title_short Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis
title_sort dapsone hypersensitivity syndrome with leukemoid reaction and severe thrombocytosis
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057120/
https://www.ncbi.nlm.nih.gov/pubmed/33889465
http://dx.doi.org/10.7759/cureus.14026
work_keys_str_mv AT pahadiyahansraj dapsonehypersensitivitysyndromewithleukemoidreactionandseverethrombocytosis
AT lakhotiamanoj dapsonehypersensitivitysyndromewithleukemoidreactionandseverethrombocytosis